DEMON-Study (DantrolenE MONitoring in anesthesia and intensive care)

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00038811

Enrollment

1500

Registered

2026-03-13

Start date

2026-03-07

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

T88.3

Interventions

Group 1: Members of the DGAI and other international anesthesiological societies who participate in the survey after receiving the link to the online survey.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Membership in: DGAI and/or other international anesthesiological professional societies

Exclusion criteria

Exclusion criteria: No consent

Design outcomes

Primary

Measure	Time frame
The primary objective of the survey, conducted as an online questionnaire, is the systematic analysis of the use of malignant hyperthermia–triggering agents in pediatric anesthesia and the associated management of dantrolene availability.	—

Secondary

Measure	Time frame
Personal experiences of anesthesiologists with malignant hyperthermia and analysis of the availability of structural resources to support the treatment of malignant hyperthermia.	—

Countries

Canada, Germany, Switzerland, United States

Contacts

Public ContactWerner Klingler

SRH Klinikum Sigmaringen

Werner.Klingler@srh.de+49 7571 100-2331

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Apr 4, 2026